INS and COVID-19: We calculated, in the studied group of 143 hospitalized patients with the moderate/severe form of COVID-19, the state of insulin resistance at the time of inclusion, at the 4-month follow-up, and at the 12-month follow-up after the hospitalization with a post-acute episode of COVID-19.